Keystone Heart acquires 510 Kardiac Devices - MassDevice

keystone-510-kardiac-devices-acquisitionKeystone Heart today said it has acquired 510 Kardiac Devices for an undisclosed amount.

The development-stage 510 Kardiac Devices is currently developing the Lim Transseptal System to meet the demands of left-sided structural heart procedures that require a transeptal approach. The system is important in procedures such as percutaneous treatment of mitral valve disease, percutaneous occlusion of the left atrial appendage and electrophysiology procedures.

“At Keystone Heart, we are dedicated to delivering innovative products that fulfill unmet needs—like our TriGUARD 3, which is the only CE Marked cerebral embolic protection device designed to cover and protect all three cerebral vessels during transcatheter heart procedures,” president and CEO Chris Richardson said in a news release. “With the increase in left-sided structural heart procedures, Interventional Cardiologists are being asked to puncture and cross the interatrial septum using specific puncture locations on challenging anatomies. Adding the Lim Transseptal System allows us to broaden our portfolio and fortify our long-term strategy of offering total package solutions for structural heart procedures.”

The Lim Transseptal System device is designed to give physicians an increased level of device control, functionality and visibility to make transseptal punctures more effective and efficient. Its intuitive handle design allows steering in two unique planes, as well as the ability to advance the dilator with precise and controlled ability. It also uses fluoroscopic and echogenic markers on the distal end to increase visibility.

“We are excited to be joining an innovative company like Keystone Heart,” said Jaime Sarabia, 510 Kardiac Devices co-founder and CEO. “Procedures requiring a transseptal approach will grow dramatically over the next several years, and the Lim Transseptal System will help to differentiate Keystone Heart as a leader within these new therapies. This partnership provides us the distinct opportunity to bring our pioneering technology into the US & Europe by partnering with a team that is known for excellent product development and go-to-market experience.”

The device is currently not cleared for use in the U.S., not approved for commercial distribution and is not CE marked.

RSS From Medical Design & Outsourcing

  • Webinar: How to protect your medical device manufacturing workers from COVID-19
    Tuesday, July 21, 2020 11:30 a.m. Eastern time / 8:30 a.m. Pacific time     As essential medtech facilities continue operations during COVID-19 and more facilities resume manufacturing, employee safety becomes a very important topic. In this webinar we will explore how to protect your medical device manufacturing workers from COVID-19. The most important step… […]
  • Webinar: How to boost value while reducing the cost of your diagnostics
    Thursday, July 30, 2020 2 p.m. Eastern time / 11:30 a.m. Pacific time     The diagnostics industry — including medical device companies, remote patient monitoring firms, and independent diagnostic testing facilities (IDTFs) — faces many challenges related to physician and patient acceptance, payor acceptance, and often daunting regulatory and compliance requirements. Whether you’re a… […]
  • Biomerics opens online medical balloon store
    Interventional and radiology device contract manufacturer Biomerics announced today that it has launched an online store to sell medical balloons. The new e-commerce platform will sell a range of off-the-shelf nylon, PET, and LDPE medical balloons, enabling engineers to develop and prototype next-generation catheters quickly, according to the Salt Lake City-based company. The online store… […]
  • How to protect connected medical devices from cyberattacks
    Today’s connected-health solutions have dramatically improved patient care. Ensuring that they simultaneously protect patients from hackers requires a closer look at their security, especially as they move to command-and-control models using commercial smartphones. Vinay Gokhale, Thirdwayv No one doubts that connecting medical devices in the Internet of Things (IoT) has delivered many benefits that have… […]
  • The Importance of Power Distribution Units in Medical Test Equipment
    Medical Test Equipment Requirement Considerations The medical industry faces numerous challenges in designing electronic and software-run devices. Increasingly sophisticated machines demonstrate growing dependency on similarly intricate electronics, driven by rapid technology development and exceptional competition. On top of it all, the Food and Drug Administration (FDA) requires extensive testing before devices are released to market. Advanced… […]
  • Manufacturing group funds $6m in projects to fight COVID-19 in Canada
    Next Generation Manufacturing Canada (NGen), the industry-led organization behind Canada’s advanced manufacturing supercluster, has announced an additional $6 million in funding for projects dedicated to fighting the COVID-19 pandemic in Canada. To date, NGen has supported a total of 19 such projects amounting to $27 million. Three companies are the latest recipients of cash from… […]
  • Medline commits $1m to organizations advancing social justice for Black Americans
    Medline Industries recently announced that will donate $1 million to four organizations working to advance diversity, inclusion and equality for Black Americans. The organizations are the Black Lives Matter, the NAACP, the National Urban League and the United Negro College Fund. The Northfield, Ill.-based company said it chose the recipients based on their missions to… […]
  • Wyss Institute lands $16m to repurpose drugs for COVID-19
    Lindsay Brownell, Wyss Institute The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded Harvard university’s Wyss Institute for Biologically Inspired Engineering $16 million to identify and test FDA-approved drugs that could be repurposed to prevent or treat COVID-19. Using its computational drug discovery pipelines and human Organ Chip technologies, the institute has already found… […]
  • FDA extends switch to virtual meetings, warns it may miss some deadlines
    The FDA said Monday that it will continue holding formal meetings with device sponsors virtually due to the COVID-19 pandemic for now. The agency also said that it may miss some deadlines in completing user-fee work on premarket device approval applications. In a Q&A document, the agency said that until further notice, all requests for… […]
  • XaTek to develop rugged ClotChip for U.S. Navy
    XaTek today announced a deal with the U.S. Navy to develop its ClotChip handheld blood coagulation reader for military deployment. The reader measures a patient’s bleeding risk from one drop of blood from a fingerstick. It will be adapted to withstand excessive impact and vibration of trauma patient support. The adaptions will be validated in… […]
  • DOD launches $100m initiative to return COVID-19-related medtech, pharma manufacturing to the U.S.
    The U.S. Department of Defense announced today that it will dedicate $100 million ized by the CARES Act to boost medtech and pharmaceutical manufacturing in the U.S. Working with DOD, the U.S. International Development Finance Corporation (DFC) launched a request for proposals from companies seeking financing under the Defense Production Act, which prioritizes government orders… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.